Melanoma

August 11, 2014August 11, 2014

Galectin Reports On Phase 1 Clinical Trial To Determine The Effectiveness Of Combined Therapies In Metastatic Melanoma Treatment

Melanoma, News

Galectin Therapeutics Inc., a pharmaceutical company focused on developing treatment options for patients with life-threatening fibrosis or cancer diagnoses, recently announced its first Phase 1 human-trial cohort, testing Galectin protein inhibitor GR-MD-02 ... Read more

August 5, 2014August 7, 2014

Debate Continues on the Future Role of Checkpoint Inhibitors in Melanoma

Melanoma, News

The future role of checkpoint inhibitors in melanoma has been the topic of recent discussion amongst oncologists, as reported in a recent OncLive video debate. Tolerability and the development of predictive ... Read more

August 5, 2014August 5, 2014

Marin County California Experiences High Rates Of Melanoma

Melanoma, News

The Cancer Prevention Institute of California and the Stanford Cancer Institute recently noted that the incidence of melanoma in Marin County, California is rapidly increasing in comparison to other regions of the ... Read more

August 4, 2014August 4, 2014

Researchers Discover New Approach Identifying Cancer Mutation Targets For Novel Melanoma Immunotherapy

Melanoma, News

A team of researchers from the National Cancer Institute (NCI), in Bethesda, Maryland, has developed a novel approach demonstrating that mutated cancer antigens recognized by T-cells are responsible for complete ... Read more

July 31, 2014July 31, 2014

Bristol-Myers Squibb Plans Submission of a Biologics License Application for Previously Treated Advanced Melanoma Drug Opdivo

Melanoma, News

Bristol-Myers Squibb plans to submit a Biologics License Application in the third quarter for its drug Opdivo for previously treated advanced melanoma, following discussions with the U.S. Food and Drug Administration, ... Read more

July 30, 2014July 30, 2014

Roche Announces Effectiveness and Safety of Novel Combination Drug Treatment for Melanoma

Melanoma, News

Swiss biotech company Roche has announced the development of a skin cancer medication treatment that has shown in a late-stage test to be effective in helping advanced patients live longer without disease ... Read more

July 30, 2014July 31, 2014

CNIO Researchers Discover More Than 40 Genes That Determine Melanoma Aggressiveness

Melanoma, News

Researchers at the Spanish National Cancer Research Center (CNIO, in the Spanish abbreviation) have identified over 40 genes that can predict the level of aggressiveness of melanoma, while distinguishing it ... Read more

July 28, 2014July 28, 2014

Melanoma Research Alliance Part of Three-Part Partnership To Further Research On Brain Metastases

Melanoma, News

A leading research funding and advocacy group for Melanoma is teaming up with two other cancer research foundations with a completely different cancer focus to pool resources for researching and ... Read more

July 25, 2014July 25, 2014

Senate Appropriations Committee Doubles Cancer Research Funding, Emphasizes Melanoma

Melanoma, News

The Senate Appropriations Committee recently approved the fiscal year 2015 Defense Appropriations bill, earmarking $50 million for the Department of Defense’s (DoD) Peer Reviewed Cancer Research Program (PRCRP) — a doubling of ... Read more

July 24, 2014July 24, 2014

Sunscreens Don’t Provide Enough Protection Against Melanoma

Melanoma, News

Even with sun protector factor (SPF) 50, sunscreen is only partially effective against the immediate radiation damage of the sun, and does not offer complete protection against melanoma, one of the ... Read more

July 17, 2014July 23, 2014

Genentech/Exelixis Phase III Melanoma Study For Vemurafenib/Cobimetinib Has PFS Extended

Melanoma, News

Genentech and Exelixis have released encouraging results from their latest clinical trial collaboration, whereby advanced melanoma patients receiving a combination of vemurafenib (Zelboraf), a BRAF inhibitor, and cobimetinib, a MEK ... Read more

July 6, 2014August 6, 2014

Melanoma Liver Metastasis Surgery Can Prolong Survival, According to Study

Melanoma, News

Melanoma liver metastasis is usually fatal, and although it is only diagnosed in 10% to 20% of patients with stage IV melanoma, the majority of patients with hepatic metastases as ... Read more